Offer - Urjas Oil for just ₹ 1 X
Triglimicure is a commercial drug that is prescribed in the form of Tablet. Diabetes are some of its major therapeutic uses. Other than this, Triglimicure has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Triglimicure. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Triglimicure also has some side effects, the most common being Nausea or vomiting, Diarrhoea, Headache. Some other side effects of Triglimicure have been listed ahead. Such side effects of Triglimicure normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Triglimicure has a Unknown effect for pregnant women and Safe effect on lactating mothers. Further, the section on Triglimicure related warnings talks about Triglimicure's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Liver Disease, Kidney Disease must refrain from the use of Triglimicure since this can cause severe adverse effects.
Additionally, Triglimicure may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to the above precautions for Triglimicure, it is important to know that it is not safe while driving, and is not habit-forming.
Triglimicure is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Triglimicure safe for pregnant women?
It is not known what effect Triglimicure will have on pregnant women, because no research work has been carried out on this till date.
Is the use of Triglimicure safe during breastfeeding?
Triglimicure is completely safe for breastfeeding women.
What is the effect of Triglimicure on the Kidneys?
There can be some harmful effects on your kidneys after taking Triglimicure. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Triglimicure on the Liver?
You may experience side effects on your liver after taking Triglimicure. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Triglimicure on the Heart?
Triglimicure may have mild side effects on the heart. Most people will never see any effect on the heart.
Triglimicure should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Triglimicure unless your doctor advises you to do so -
Is this Triglimicure habit forming or addictive?
No, there is no any evidence that Triglimicure is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Triglimicure. So it is best to avoid driving.
Is it safe?
Triglimicure is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Triglimicure is unable to treat or cure mental disorders.
Interaction between Food and Triglimicure
Due to the absence of research, it is difficult to say how Triglimicure and food will interact.
Interaction between Alcohol and Triglimicure
It is difficult to say anything about the effect of Triglimicure and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033